Cargando…
A commentary on the discrepancy between blood and tumour BRCA testing: An open question
Autores principales: | De Paolis, Elisa, Marchetti, Claudia, Concolino, Paola, Scambia, Giovanni, Urbani, Andrea, Fagotti, Anna, Minucci, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543799/ https://www.ncbi.nlm.nih.gov/pubmed/35319826 http://dx.doi.org/10.1111/1471-0528.17158 |
Ejemplares similares
-
Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation
por: De Paolis, Elisa, et al.
Publicado: (2021) -
BRCA testing delay during the COVID-19 pandemic: How to act?
por: Minucci, Angelo, et al.
Publicado: (2020) -
BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic
por: Minucci, Angelo, et al.
Publicado: (2020) -
A Whole Germline BRCA2 Gene Deletion: How to Learn from CNV In Silico Analysis
por: Scaglione, Giovanni Luca, et al.
Publicado: (2018) -
High-resolution melting analysis coupled with next-generation sequencing as a simple tool for the identification of a novel somatic BRCA2 variant: a case report
por: Costella, Alessandra, et al.
Publicado: (2018)